1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Opioid Receptor
  4. μ Opioid Receptor/MOR Isoform
  5. μ Opioid Receptor/MOR Inhibitor

μ Opioid Receptor/MOR Inhibitor

μ Opioid Receptor/MOR Inhibitors (4):

Cat. No. Product Name Effect Purity
  • HY-124754
    Navacaprant
    Inhibitor 99.97%
    Navacaprant (BTRX-335140) is a selective and orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. Navacaprant endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats. Navacaprant distributes well into the CNS and can be used for the research of neuropathy.
  • HY-N0398
    Sec-O-Glucosylhamaudol
    Inhibitor 99.81%
    Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect.
  • HY-P1596
    Gluten Exorphin C
    Inhibitor 98.97%
    Gluten exorphin C is an opioid peptide derived from wheat gluten. Its IC50 values are 40 μM and 13.5 μM for μ opioid and δ opioid activities in the GPI and MVD assays, respectively.
  • HY-120846
    CHIR 4531
    Inhibitor
    CHIR 4531, a trimer peptide, is a opiate ligand that binds to the mu-opiate receptor with a Ki of 6 nM.